A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

I.V. Fat Emulsion (Intralipid)

Lipid Emulsion class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2004-04-01
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
367 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is I.V. Fat Emulsion used for?

I.V. Fat Emulsion is a Lipid Emulsion medication tracked in Medicare Part D.

Is there a generic for I.V. Fat Emulsion?

No. I.V. Fat Emulsion is brand-only with no generic equivalents currently in market.

How much does my plan pay for I.V. Fat Emulsion?

NADAC pricing data not currently available for this drug.

Is I.V. Fat Emulsion on the FDA shortage list?

No. I.V. Fat Emulsion is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Lipid Emulsion4 alternatives in D1
01
I. V. Fat Emulsion
Brand: Intralipid
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Olive Oil and Soybean Oil
Brand: Clinolipid
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Smoflipid
Lipid Emulsion
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Soybean Oil
Brand: NutriLipid I.V. Fat Emulsion
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.